Dr Mattia Rediti, medical oncologist and PhD student at the Breast Cancer...
Dr Maja Van Goistenhoven, a gynaecologist in formation at the KULeuven,...
Dr Karen Van Baelen, a PhD researcher at the KULeuven, is currently doing a...
Dr Edoardo Isnaldi and François Richard, both working at the Laboratory of...
Prof Duhoux from the oncology department of the King Albert II institute of the...
Invasive lobular breast carcinoma (ILC) represents 5 to 15% of all invasive...
The levonorgestrel intra-uterine device (LNG-IUD) is a widely used...
Tucatinib is an oral HER2-targeted therapy that was approved by the FDA in...
One year of adjuvant trastuzumab with 12 cycles of weekly paclitaxel represents...
The 2020 ASCO-CAP guidelines recommended ER Low Positive as new reporting...